Computer-assisted subtyping and prognosis for non-small cell lung cancer patients with unresectable tumor
Abstract
Background The histological classification or subtyping of non-small cell lung cancer is essential for systematic therapy decisions. Differentiating between the two main subtypes of pulmonary adenocarcinoma and squamous cell carcinoma highlights the considerable differences that exist in the prognosis of patient outcomes. Physicians rely on a pathological analysis to reveal these phenotypic variations that requires invasive methods, such as biopsy and resection sample, but almost 70% of tumors are unresectable at the point of diagnosis. Method A computational method that fuses two frameworks of computerized subtyping and prognosis was proposed, and it was validated against publicly available dataset in The Cancer Imaging Archive that consisted of 82 curated patients with CT scans. The accuracy of the proposed method was compared with the gold standard of pathological analysis, as defined by theInternational Classification of Disease for Oncology (ICD-O). A series of survival outcome test cases were evaluated using the Kaplan-Meier estimator and log-rank test (p-value) between the computational method and ICD-O. Results The computational method demonstrated high accuracy in subtyping (96.2%) and good consistency in the statistical significance of overall survival prediction for adenocarcinoma and squamous cell carcinoma patients (p Conclusion The findings in this study support the idea that quantitative analysis is capable of representing tissue characteristics, as offered by…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Saad et al. demonstrated that radiomics could differentiate NSCLC from peripherally located small-cell lung cancer, achieving an AUC of 0.93.
“Finally, Saad et al. demonstrated that radiomics could differentiate NSCLC from peripherally located small-cell lung cancer (SCLC), achieving an AUC of 0.93 [32].”
From Artificial Intelligence in Oncologic Thoracic Surgery: Clinical Decision Support and Emerging Applications (2026) · cites this paper as [32]
Cited by
Sorted by citations
Petrella, F., & Rizzo, S. (2026) · Cancers · doi:10.3390/cancers18020246 · Cited by 10 · see citing works
- Authors
- Saad, M., & Choi, T.-S.
- Venue
- Computerized Medical Imaging and Graphics
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 67
- Pages
- 1-8
- ISSN
- 0895-6111
- Cited by
- 20
- References
- 0
- Language
- en
- Funders
- Korea Government (MSIP) (NRF-2015R1A2A2A01002734)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review